Home
Lynx1 Capital Management reported a 21% stake in Passage BIO PASG · 673,759 sh
Trade details
- Type
- 5% stake report
- Report
- 13D
- Stake
- 21%
- Last report
- 19.6% · filed 25/11/14
- Shares held
- 673,759 sh
- Class
- Common Stock, par value $0.0001 per share
- Stock
- Passage BIO PASG
- Holder
- Lynx1 Capital Management
- Event date
- 26/06/25
- Filed
- 26/07/02
21% stake · +1.4pp from the last report
- Stake
- 21%
- Last report
- 19.6%
- Since last report
- +1.4pp
Passage BIO trades, last 26 weeks
What else happened in Passage BIO around then
Filed or reported within 30 days of the trade day · 05/26~07/25Lynx1 Capital Management's other 5% stake reports
- Lynx1 Capital Management
5% stakeTScan Therapeutics
5% stakeTScan Therapeutics
TCRX
13.1% stake
20,519,148 sh
13.1% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeStoke Therapeutics
5% stakeStoke Therapeutics
STOK
6.5% stake
4,038,404 sh
6.5% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeC4 Therapeutics
5% stakeC4 Therapeutics
CCCC
9.99% stake
15,423,691 sh
9.99% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeiBio
5% stakeiBio
IBIO
5.4% stake
2,807,016 sh
5.4% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeGH Research
5% stakeGH Research
GHRS
19.3% stake
13,263,288 sh
19.3% stake
Filed 08/14
